Ndị ọrụ ọgwụ ọjọọ ugbu a dị ugbu a iji mesoo ọrịa HIV
A na-ahazi ọgwụ ndị na- agwọ ọrịa nje n'ime klas ise na-adabere na usoro nke usoro ndụ ndụ HIV nke ha na-egbochi. Taa, e nwere mmadụ iri abụọ na asaa (ndị a na-akpọ ọgwụ ọgwụ) na ọgwụ iri na abụọ (FDC) gụnyere ọgwụ abụọ ma ọ bụ karịa. E nwere ike iji asaa nke FDC mee ihe dịka otu mkpụrụ ọgwụ, otu ugboro kwa ụbọchị, na-eme ka nlekọta ọgwụgwọ dị mma na ịdị mfe nke ojiji.
A na-eji usoro ọgwụgwọ na-agwọ ọrịa na-agwọ ọrịa na-eji ọgwụ atọ dị iche iche eme ihe, usoro a maara nke ọma dị ka HAART (ọgwụgwọ antiretroviral nke ukwuu). Ebe ọ bụ na mmalite ya na 1996, HAART aghọwo ọganihu nke ukwuu ugbu a, na-enyekwa obere mmetụta ndị ọzọ na ọgwụgwọ ka ukwuu karịa mgbe ọ bụla ọzọ.
N'ezie, usoro ọgwụgwọ atọ nwere ike ịbịa n'oge na-adịghị anya bụ ọgwụgwọ ọgwụ abụọ dị ka Juluca (dolutegravir + rilpivirine) ugbu a ka a kwadoro maka ọgwụgwọ zuru oke, ọgwụ nile nke nje HIV.
Na February 7, 2018, a kwadoro ọgwụ ọhụrụ ọgwụ nje HIV, bictegravir, iji mee ihe maka US Food and Drug Administration dịka ngwepụta nke ọgwụ FDC, Biktarvy.
| Klaasị ọgwụ ọjọọ | Aha aha | Aha njirimara | Ndị toworo eto | Ntughari nri |
| Ndị na-eme ihe ntinye | Fuzeon | enfuvirtide, T-20 | 90mg (1 ml) injected ugboro abụọ kwa ụbọchị | Ọ dịghị |
| Selzentry, Celsentri | maraviroc | Otu mbadamba 150mg ugboro abụọ, otu mbadamba 300mg ugboro abụọ kwa ụbọchị, ma ọ bụ mbadamba nkume 300mg ugboro abụọ kwa ụbọchị, dabere na usoro ọgwụ ọjọọ | Ọ dịghị | |
| Ndị na-agwọ ọrịa Pharmacokinetic (aka nje HIV) | Norvir | ritonavir | Na-eji nkà na-emechi protease, a na-eji Norvir mee ka ọ bụrụ nanị iji "bulie" usoro ọgwụgwọ ọgwụ ahụ nke ndị ọzọ na-echebe protease (PI); ndị na-ede akwụkwọ kwesịrị ịjụ ozi zuru oke mgbe ha na-ejikọta PI | Emere ma ọ bụ na-enweghị nri |
| Ụdị | ọkpụkpụ | 150mg otu ugboro kwa ụbọchị; n'ụzọ dị irè onye na-emechi CYP3A, a na-eji Tybost mee ihe iji "bulie" usoro ọgwụgwọ ọgwụ ahụ nke ọtụtụ ndị na-egbochi protease (PI) | Eji ya na nri | |
| Ndị na-emechi mmekọrịta | Nwa nwanyi | raltegravir | Otu 400mg mbadamba nkume ugboro abụọ kwa ụbọchị | Emere ma ọ bụ na-enweghị nri |
| Tivicay | dolutegravir | Otu mbadamba 50mg kwa ụbọchị maka ndị ọrịa na-adịghị agwọta; otu mbadamba 50mg ugboro abụọ kwa ụbọchị maka ndị ọrịa nwere ahụike na-eguzogide Isentress | Emere ma ọ bụ na-enweghị nri | |
| Họrọ | elvitegravir | Mbadamba 85mg ma ọ bụ 150mg were otu ugboro ma ọ bụ ugboro abụọ kwa ụbọchị, yana Norvir na onye nchịkwa protease ọzọ; na-ezo aka na- edozi eserese maka ụfọdụ dosages | Eji ya na nri | |
| Ntughari na Nucleotide Reverse Transcriptase Inhibitors (NRTIs / NtRTIs) | Emtriva | emtricitabine | Otu mbadamba 100mg otu ugboro kwa ụbọchị, ma ọ bụ 150mg mbadamba nkume ugboro abụọ kwa ụbọchị | Emere ma ọ bụ na-enweghị nri |
| Epivir | lamivudine | Otu mbadamba 300mg otu ugboro kwa ụbọchị, ma ọ bụ 150mg mbadamba nkume ugboro abụọ kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Retrovir | AZT, zidovudine | Otu mbadamba nkume 300mg ugboro abụọ kwa ụbọchị | Nri nwere ike ime ka obi ghara iru ala | |
| Videx EC | didanosine, ddI | Otu mkpụrụ mmiri 400m gụrụ otu ugboro kwa ụbọchị; ma ọ bụ otu 200mg capsule ewere otu ugboro kwa ụbọchị maka ndị ọrịa n'okpuru 133 lbs (60kg) | Emere na afo efu | |
| Ike | tenofovir | Otu 300mg mbadamba otu ugboro kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Zerit | stavudine | Otu 40mg capsule were 12 hourly maka ọrịa 133 lb (60kg) na ihe; ma ọ bụ 30mg capsule were 12 awa maka ndị ọrịa na-erughị 133 lbs (60kg) | Emere ma ọ bụ na-enweghị nri | |
| Ziagen | abacavir | Mbadamba nkume 300mg dị otu ugboro kwa ụbọchị, ma ọ bụ mbadamba 300mg ugboro abụọ kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Ndị na-eme ihe na-emeghị ihe ọ bụla na-enweghị atụ (NNRTIs) | Nduzi | rilpivirine | Otu mbadamba 25mg otu ugboro kwa ụbọchị | Emere ya nri |
| Ịdị mma | etravirine | Otu mbadamba 200mg ugboro abụọ kwa ụbọchị | Emere ya nri | |
| Akwụkwọ edemede | delavirdine | Akara mbadamba 200m dị ugboro atọ kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Sustiva | efavirenz | Otu mbadamba 600mg otu ugboro kwa ụbọchị | Kwunye na afo efu | |
| Viramune XR | nevirapine | Ntughari nke otu 200mg Viramune mbadamba kwa ụbọchị maka ụbọchị 14, mgbe ahụ otu 100mg Viramune XR mbadamba kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Ndị na-eme ihe nchebe (PI) | Aptivus | tipranavir | Eji 250mg capsules were 200mg Norvir abụọ kwa ụbọchị | Ihe kachasị mma na nri |
| Crixivan | indinavir | Achịkpu 400mg eji 100mg ma ọ bụ 200mg Norvir abụọ kwa ụbọchị (kachasị amasị), ma ọ bụ 200mg capsules were kwa awa 8 | Na Norvir, were nri ma ọ bụ na-enweghị nri; na-enweghị Norvir, weghasị afo | |
| Kpọọ | saquinavir | Mbadamba nkume 500mg jiri 100mg Norvir ugboro abụọ kwa ụbọchị | Eji nri ma ọ bụ n'ime awa 2 eri nri | |
| Kaletra | 200 mg lopinavir + 50mg Norvir (Cheta - lopinavir bụ naanị dị ka akụkụ nke Kaletra) | Mbadamba nkume abụọ kwa ụbọchị; mbadamba nkume anọ kwa ụbọchị ka a na-anabata maka ndị ọrịa na-adịghị agwọta ma ọ bụ ndị ọrịa na-erughị ngbanwe atọ karịa njikọta lopinavir | Emere ma ọ bụ na-enweghị nri | |
| Lexiva, Telzir | fosamprenavir | Mbadamba nkume 200mg ugboro abụọ kwa ụbọchị; ma ọ bụ mpempe 700mg dị 100mg 100mg otu ugboro kwa ụbọchị; ma ọ bụ 700mg mbadamba na 100mg Norvir abụọ kwa ụbọchị maka ndị ọrịa na ọdịda PI ada | Emere ma ọ bụ na-enweghị nri | |
| Prezista | darunavir | Otu mbadamba 800mg (ma ọ bụ mbadamba nkume 200m) were 100mg Norvir ugboro kwa ụbọchị; ma ọ bụ 600mg mbadamba na 100mg Norvir ugboro abụọ kwa ụbọchị maka ndị ọrịa na ọkwa dị elu nke na-eguzogide Prezista | Eji ya na nri | |
| Reyataz | atazanavir | Akara 200mg capsules were otu ugboro kwa ụbọchị, ma ọ bụ 300mg (ma ọ bụ 150mg) capsules were na 100mg Norvir ugboro kwa ụbọchị | Eji ya na nri nri | |
| Viracept | nelfinavir | Mbadamba nkume 625mg ugboro abụọ kwa ụbọchị, ma ọ bụ mbadamba nkume 250mg ugboro abụọ kwa ụbọchị, ma ọ bụ mbadamba nkume 250mg ugboro atọ kwa ụbọchị | Emere ya nri ma ọ bụ nri nri | |
| Njikọ Ụkwụ Dịrị (FDC) Drugs | Combivir | 300mg Retrovir + 150mg Epivir | Otu mbadamba ihe ugboro abụọ kwa ụbọchị | Nri nwere ike ime ka obi ghara iru ala |
| Epzicom | 600mg Ziagen + 300mg Epivir | Otu mbadamba otu ugboro kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Evotaz | 300mg Reyataz + 150mg Tybost | Otu mbadamba otu ugboro kwa ụbọchị | Eji ya na nri | |
| Prezcobix | 800mg Prezista + 150mg Tybost | Otu mbadamba otu ugboro kwa ụbọchị | Eji ya na nri | |
| Truvada | 300mg Viread + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị | Emere ma ọ bụ na-enweghị nri | |
| Ngwakọta na-adabere na ya (FDC) Drugs | Atripla | 600mg Sustiva + 300mg Viread + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Kasị mma na afo efu |
| Biktarvy | 50mg bictegravir + 200mg Viread + 25mg tenofovir alafenamide | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Emere ma ọ bụ na-enweghị nri | |
| Emecha | 25mg Edurant + 300mg + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Ihe kacha mma eji nri | |
| Genvoya | 150mg Vitekta + 150mg Tybost + 10mg tenofovir alafenamide + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Eji ya na nri | |
| Juluca | 50mg Tivicay + 25mg na-eduzi | Otu mbadamba otu ugboro kwa ụbọchị | Eji ya na nri | |
| Odefsey | 25mg Edurant + 25mg tenofovir alafenamide + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Eji ya na nri | |
| Dupuo | 150mg Vitekta + 150mg Tybost + 300mg + 200mg Emtriva | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Eji ya na nri | |
| Nkeji abuo | 600mg Ziagen + 300mg Epivir + 50mg Tivicay | Otu mbadamba otu ugboro kwa ụbọchị; ọ dịghị onye ọ bụla ọzọ na-ahụ maka ọgwụ mgbochi | Emere ma ọ bụ na-enweghị nri | |
| Na-agagharị | 300mg Ziagen + 300mg Retrovir + 150mg Epivir | Otu mbadamba ihe ugboro abụọ kwa ụbọchị; enwere ike ịhazi ya naanị ya ma ọ bụ ya na ndị ọzọ antiretroviral | Ihe kacha mma eji nri |
Isi:
> Ngalaba Na-ahụ Maka Ahụ Ike na Ọrụ Ndị Mmadụ. "Ọrịa AIDS na- adabere na FDA " AIDSInfo. Washington, DC; emelitere February 28, 2018.